Overview Services Applications Get Started FAQs Products
Mapping Spatial RNA Regulatory Landscapes with Precision
At Creative Biolabs, we leverage cutting-edge ChIRP (Chromatin Isolation by RNA Purification) technology to decode the intricate spatial interactions between non-coding RNAs and their protein partners across the genome. Designed exclusively for preclinical research, our platform integrates proprietary hybridization capture, high-resolution sequencing, and AI-driven bioinformatics to deliver unparalleled insights into RNA-centric regulatory networks in disease biology, epigenetics, and target discovery.
Technology Overview: The ChIRP Advantage
ChIRP targets endogenous RNA molecules using tiled, biotinylated antisense oligonucleotides, enabling ultra-specific isolation of RNA-protein-chromatin complexes. This approach overcomes the limitations of traditional methods through:
-
Spatial Specificity: Direct capture of architectural RNAs (e.g., lncRNAs, circRNAs) within native chromatin contexts.
-
Multi-Omic Resolution: Simultaneous mapping of RNA-protein interactions and chromatin occupancy.
-
Ultra-Low Background: Stringent washing eliminates non-specific binding, validated via scramble-oligo controls.
Featured Services
End-to-End Solutions - Comprehensive Service Offerings
Delivering modular, hypothesis-driven research packages to help you decode RNA-centric regulatory architectures.
-
Endogenous Complex Isolation Service
We offer comprehensive support to capture native RNA-chromatin-protein interactions in situ, solving the critical challenge of preserving transient biological states. Our optimized workflows enable researchers to map physiological complexes with spatial fidelity, bringing unprecedented clarity to RNA-centric regulatory mechanisms.
-
Architectural RNA Mapping Solutions
We deliver end-to-end expertise in profiling structural non-coding RNAs (e.g., scaffolding lncRNAs), addressing the technical hurdles of low-abundance target isolation. By implementing species-specific hybridization strategies, we help clients decode 3D genome organization mechanisms, accelerating discoveries in nuclear architecture and epigenetic reprogramming. This advances fundamental research in development and oncology.
-
Dynamic Network Analysis Support
Our team provides specialized solutions for tracking RNA interactome rewiring across time-series or perturbation conditions. We overcome the limitations of static snapshots through rigorous longitudinal designs, enabling clients to reconstruct dynamic regulatory cascades in differentiation, stress response, or drug treatment models. This reveals transient therapeutic vulnerabilities inaccessible through conventional approaches.
Fig.1 ChIRP Service Workflow.
Advanced Bioinformatics
Our customizable analytical framework provides scalable computational insights:
Analysis Tier
|
Deliverables
|
RNA-Chromatin Hubs
|
Identification of topologically associating domains (TADs) anchored by target RNAs; enhancer-promoter loop mapping
|
Functional Annotation
|
Integration with ENCODE/TCGA datasets; pathway enrichment
|
3D Network Modeling
|
Visualization of RNA-protein-chromatin interactomes; cooperative regulator identification
|
Disease Context
|
Correlation with disease-associated SNPs; survival impact analysis in public cohorts
|
Related RNA-Protein Interaction Services
RIP-Seq Based Analysis
-
Native Complex Profiling: Physiological RBP interactions identified without crosslinking artifacts
-
Transcriptome-Wide Screening: Genome-scale mapping of steady-state RNA-protein associations
-
RBP Network Discovery: Foundational analysis for regulatory mechanism hypotheses
CLIP-Seq Based Analysis
-
Crosslink-Captured Interactions: Covalent stabilization of transient RNA-protein complexes
-
Single-Nucleotide Resolution: High-precision binding site localization
-
Dynamic Interaction Modeling: Temporal regulation analysis of RBP activity
RAP Based Analysis
-
Endogenous Complex Capture: In vivo preservation of native RNA-protein topologies
-
Comprehensive Interactomes: System-wide identification of direct/indirect interactors
-
Functional Module Discovery: Deconvolution of cooperative regulatory units
mRNA Interactome Capture
-
Translatome Profiling: Global snapshot of mRNA-bound proteomes
-
RBP Activity Benchmarking: Basal interaction network establishment
-
Translational Machinery Analysis: Ribosome-associated factor characterization
Emerging Research Applications
1. lncRNA in 3D Genome Organization
-
Architectural RNA Mechanisms
Recent studies demonstrate how Xist and NEAT1 lncRNAs scaffold nuclear compartments, with spatial disruption linked to oncogenic gene activation.
-
CRISPR-Guided Perturbation
Combining ChIRP with dCas9-mediated lncRNA knockdown reveals compensatory chromatin rewiring in stem cell differentiation models.
2. Viral RNA-Host Interfaces
-
Latency Regulation
ChIRP-MS uncovered how Kaposi's sarcoma-associated herpesvirus (KSHV) lncRNA PAN recruits host ubiquitin ligases to evade immune surveillance.
-
Therapeutic Target Screening
High-throughput ChIRP identifies host dependency factors bound by SARS-CoV-2 regulatory RNAs.
3. Cancer Epigenetic Reprogramming
-
Oncogenic lncRNA Circuits
Integrated analysis of PVT1 revealed its role in stabilizing MYC protein at enhancer clusters, promoting chemoresistance in PDAC.
-
Metastatic Niche Remodeling
Tumor-derived lncRNAs (e.g., MALAT1) hijack nuclear matrix proteins to alter collagen architecture in pre-metastatic lungs.
4. Neurodevelopmental Dynamics
-
Imprinted Loci Regulation
Single-cell ChIRP uncovered cell-type-specific allelic silencing by Kcnq1ot1 lncRNA during cortical development.
-
Phase Separation Pathology
Aberrant FUS-RNA granules disrupt chromatin compartmentalization in ALS models, detectable via ChIRP-imaging fusion.
Partner with Creative Biolabs
Why Choose Us?
Deep Expertise
-
10+ years pioneering spatial RNA interactome research.
-
We've successfully delivered 50+ non-coding RNA projects, empowering breakthroughs in nuclear architecture and disease mechanisms.
Innovation Leadership
-
Proprietary approaches for unprecedented resolution.
-
Overcome limitations of traditional methods with our optimized platform designed for complex biological contexts.
Pure Research Integrity
-
100% preclinical focus with zero therapeutic claims.
-
Your data is generated under strict research ethics guidelines, ensuring publication-ready integrity.
Initiate Your Project
Share your target RNA, biological model (cell lines, organoids, or tissues), and research goals. Our specialists will provide:
-
Customized oligo design strategy
-
Tissue-specific protocol optimization
-
Multi-omic integration roadmap
[Contact Us] Schedule a technical consultation within 24 hrs.
FAQs
Q1: How does ChIRP differ from CLIP-Seq?
A: ChIRP targets endogenous RNAs without antibodies, capturing RNA-chromatin-protein ternary complexes, while CLIP-Seq focuses on protein-centric RNA binding.
Q2: Can ChIRP analyze low-abundance lncRNAs?
A: Yes. Our signal amplification workflow detects RNAs at ≥5 copies/cell.
Q3: What sample types are compatible?
A: Cultured cells (≥2M), fresh/frozen tissues (≥20mg), FFPE sections. Species-agnostic.
Q4: Can functional validation be integrated?
A: Yes. Our platform supports combination with targeted gene editing systems to interrogate regulatory node functionality, enabling hypothesis-driven mechanistic studies.
Featured mRNA Products
Reference
-
Mi, Xuelong, et al. "Fast, accurate, and versatile data analysis platform for the quantification of molecular spatiotemporal signals." Cell 188.10 (2025): 2794-2809. Distributed under Open Access license CC BY-NC 4.0, without modification. https://doi.org/10.1016/j.cell.2025.03.012
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.